Archer Investment Corp Eagle Pharmaceuticals, Inc. Transaction History
Archer Investment Corp
- $386 Billion
- Q1 2025
A detailed history of Archer Investment Corp transactions in Eagle Pharmaceuticals, Inc. stock. As of the latest transaction made, Archer Investment Corp holds 350 shares of EGRX stock, worth $689. This represents 0.0% of its overall portfolio holdings.
Number of Shares
350
Previous 350
-0.0%
Holding current value
$689
Previous $175,000
96.0%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding EGRX
# of Institutions
10Shares Held
453KCall Options Held
0Put Options Held
0-
Black Rock Inc. New York, NY353KShares$694,9410.0% of portfolio
-
Ajo Vista, LLC Boston, MA56.4KShares$111,1820.92% of portfolio
-
Barclays PLC London, X014.2KShares$28,0390.0% of portfolio
-
Stanley Laman Group, Ltd. Berwyn, PA12KShares$23,6400.0% of portfolio
-
Hightower 6 M Holding, LLC8.86KShares$17,4580.02% of portfolio
About EAGLE PHARMACEUTICALS, INC.
- Ticker EGRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 13,015,900
- Market Cap $25.6M
- Description
- Eagle Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology in the United States. The company offers Ryanodex for malignant hyperthermia; and Belrapzo and Bendeka for chronic lymphocytic leukemia and in...